357 related articles for article (PubMed ID: 16246413)
1. Dual growth factor-induced angiogenesis in vivo using hyaluronan hydrogel implants.
Peattie RA; Rieke ER; Hewett EM; Fisher RJ; Shu XZ; Prestwich GD
Biomaterials; 2006 Mar; 27(9):1868-75. PubMed ID: 16246413
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of in vivo angiogenesis by cytokine-loaded hyaluronic acid hydrogel implants.
Peattie RA; Nayate AP; Firpo MA; Shelby J; Fisher RJ; Prestwich GD
Biomaterials; 2004 Jun; 25(14):2789-98. PubMed ID: 14962557
[TBL] [Abstract][Full Text] [Related]
3. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF.
Pike DB; Cai S; Pomraning KR; Firpo MA; Fisher RJ; Shu XZ; Prestwich GD; Peattie RA
Biomaterials; 2006 Oct; 27(30):5242-51. PubMed ID: 16806456
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of in vivo angiogenesis using dual growth factor-loaded crosslinked glycosaminoglycan hydrogels.
Riley CM; Fuegy PW; Firpo MA; Shu XZ; Prestwich GD; Peattie RA
Biomaterials; 2006 Dec; 27(35):5935-43. PubMed ID: 16950508
[TBL] [Abstract][Full Text] [Related]
5. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor.
Cai S; Liu Y; Zheng Shu X; Prestwich GD
Biomaterials; 2005 Oct; 26(30):6054-67. PubMed ID: 15958243
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of in vivo angiogenesis by in situ crosslinked, dual growth factor-loaded, glycosaminoglycan hydrogels.
Elia R; Fuegy PW; VanDelden A; Firpo MA; Prestwich GD; Peattie RA
Biomaterials; 2010 Jun; 31(17):4630-8. PubMed ID: 20227760
[TBL] [Abstract][Full Text] [Related]
7. Microvascular maturity elicited in tissue treated with cytokine-loaded hyaluronan-based hydrogels.
Hosack LW; Firpo MA; Scott JA; Prestwich GD; Peattie RA
Biomaterials; 2008 May; 29(15):2336-47. PubMed ID: 18313745
[TBL] [Abstract][Full Text] [Related]
8. Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization.
Ishihara M; Obara K; Ishizuka T; Fujita M; Sato M; Masuoka K; Saito Y; Yura H; Matsui T; Hattori H; Kikuchi M; Kurita A
J Biomed Mater Res A; 2003 Mar; 64(3):551-9. PubMed ID: 12579570
[TBL] [Abstract][Full Text] [Related]
9. Bladder tissue engineering: tissue regeneration and neovascularization of HA-VEGF-incorporated bladder acellular constructs in mouse and porcine animal models.
Loai Y; Yeger H; Coz C; Antoon R; Islam SS; Moore K; Farhat WA
J Biomed Mater Res A; 2010 Sep; 94(4):1205-15. PubMed ID: 20694987
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronan oligosaccharides promote excisional wound healing through enhanced angiogenesis.
Gao F; Liu Y; He Y; Yang C; Wang Y; Shi X; Wei G
Matrix Biol; 2010 Mar; 29(2):107-16. PubMed ID: 19913615
[TBL] [Abstract][Full Text] [Related]
11. Sequential delivery of dexamethasone and VEGF to control local tissue response for carbon nanotube fluorescence based micro-capillary implantable sensors.
Sung J; Barone PW; Kong H; Strano MS
Biomaterials; 2009 Feb; 30(4):622-31. PubMed ID: 18996588
[TBL] [Abstract][Full Text] [Related]
12. In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings.
Norton LW; Tegnell E; Toporek SS; Reichert WM
Biomaterials; 2005 Jun; 26(16):3285-97. PubMed ID: 15603824
[TBL] [Abstract][Full Text] [Related]
13. Photo-crosslinkable and biodegradable Pluronic/heparin hydrogels for local and sustained delivery of angiogenic growth factor.
Yoon JJ; Chung HJ; Park TG
J Biomed Mater Res A; 2007 Dec; 83(3):597-605. PubMed ID: 17503533
[TBL] [Abstract][Full Text] [Related]
14. Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis.
Patil SD; Papadmitrakopoulos F; Burgess DJ
J Control Release; 2007 Jan; 117(1):68-79. PubMed ID: 17169457
[TBL] [Abstract][Full Text] [Related]
15. Fabrication of poly(ethylene glycol) hydrogel micropatterns with osteoinductive growth factors and evaluation of the effects on osteoblast activity and function.
Subramani K; Birch MA
Biomed Mater; 2006 Sep; 1(3):144-54. PubMed ID: 18458396
[TBL] [Abstract][Full Text] [Related]
16. An injectable hyaluronic acid-tyramine hydrogel system for protein delivery.
Lee F; Chung JE; Kurisawa M
J Control Release; 2009 Mar; 134(3):186-93. PubMed ID: 19121348
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of angiogenic activities of hyaluronan oligosaccharides of defined minimum size.
Cui X; Xu H; Zhou S; Zhao T; Liu A; Guo X; Tang W; Wang F
Life Sci; 2009 Oct; 85(15-16):573-7. PubMed ID: 19720068
[TBL] [Abstract][Full Text] [Related]
18. Enhanced angiogenic efficacy through controlled and sustained delivery of FGF-2 and G-CSF from fibrin hydrogels containing ionic-albumin microspheres.
Layman H; Li X; Nagar E; Vial X; Pham SM; Andreopoulos FM
J Biomater Sci Polym Ed; 2012; 23(1-4):185-206. PubMed ID: 21192837
[TBL] [Abstract][Full Text] [Related]
19. Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF.
Nillesen ST; Geutjes PJ; Wismans R; Schalkwijk J; Daamen WF; van Kuppevelt TH
Biomaterials; 2007 Feb; 28(6):1123-31. PubMed ID: 17113636
[TBL] [Abstract][Full Text] [Related]
20. Effect of gelatin on heparin regulation of cytokine release from hyaluronan-based hydrogels.
Peattie RA; Pike DB; Yu B; Cai S; Shu XZ; Prestwich GD; Firpo MA; Fisher RJ
Drug Deliv; 2008 Aug; 15(6):389-97. PubMed ID: 18686083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
